Katherine Cruz Gonzalez
Psychiatric/Mental Health · Nashville, TNNPI 1255089348
Payments from drug & device makers
Across 246 payments — averaging $24.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$824
- AbbVie$623
- Teva Pharmaceuticals USA, Inc.$543
- Axsome Therapeutics, Inc.$526
- plus $1K from 14 others
What the payments were for
- Food & beverage$6,047100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 40 | $1,026 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 33 | $1,023 |
| Alkermes, Inc. | 28 | $824 |
| AbbVie | 39 | $623 |
| Teva Pharmaceuticals USA, Inc. | 21 | $543 |
| Axsome Therapeutics, Inc. | 16 | $526 |
| Vanda Pharmaceuticals Inc. | 6 | $231 |
| Corium, LLC | 10 | $202 |
| Otsuka America Pharmaceutical, Inc. | 9 | $188 |
| Supernus Pharmaceuticals, Inc. | 13 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $148 |
| Noven Therapeutics, LLC | 7 | $133 |
| Johnson & Johnson | 2 | $114 |
| Lundbeck LLC | 5 | $101 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| E.r. Squibb & Sons, L.L.C. | 2 | $48 |
| Harmony Biosciences LLC | 1 | $24 |
| Biogen | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Indivior Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,047 in reported general payments places this provider in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 19 | $707 |
| Duloxetine Hcl | 29 | $517 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $466 |
| Lamotrigine | 40 | $306 |
| Lorazepam | 18 | $232 |
| Buspirone Hcl | 30 | $224 |
| Clonazepam | 38 | $187 |
| Quetiapine Fumarate | 11 | $184 |
| Sertraline Hcl | 19 | $181 |
| Bupropion XlBupropion Hcl | 11 | $169 |
| Trazodone Hcl | 19 | $122 |
| Hydroxyzine Pamoate | 13 | $104 |
| Mirtazapine | 18 | $98 |
| Alprazolam | 13 | $8 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Nashville
- Kristian DambrinoNashville$449K
- Lauren HansenNashville$263K
- Aaron JonesNashville$20K
- Kathleen McCoyNashville$12K
- Preeti SrivastavaNashville$11K
- Kersten WoodleeNashville$10K
- Ariel NewtonNashville$10K
- Robert McKeownNashville$10K
- Debra YorkNashville$9K
- Laura MelaroBolivar$682K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.